Published in Invasion Metastasis on January 01, 1982
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A (2004) 5.32
AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A (2006) 4.66
Targeted drug delivery to tumors: myths, reality and possibility. J Control Release (2011) 2.69
DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res (2011) 1.73
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J Nanobiotechnology (2011) 1.39
Heterogeneous vascular dependence of tumor cell populations. Am J Pathol (2001) 1.31
Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res (2008) 1.18
Ionizing radiation induces stemness in cancer cells. PLoS One (2012) 1.12
Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis. Prostate (2010) 1.04
Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Lab Invest (2008) 1.00
Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines. Br J Cancer (1987) 0.96
Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. PLoS One (2015) 0.87
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors. Cancers (Basel) (2012) 0.85
Regulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1. Curr Pharmacol Rep (2015) 0.79
From Reductionism to Holism: Systems-oriented Approaches in Cancer Research. Glob Adv Health Med (2012) 0.76
n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma. Int J Mol Sci (2017) 0.75
Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives. Oncol Lett (2017) 0.75
Measurement of the translational mobility of concanavalin A in glycerol-saline solutions and on the cell surface by fluorescence recovery after photobleaching. Biochim Biophys Acta (1976) 6.04
The pathogenesis of cancer metastasis. Nature (1980) 5.74
Measurement of the lateral mobility of cell surface components in single, living cells by fluorescence recovery after photobleaching. J Supramol Struct (1976) 4.40
Membrane fusion. Biochim Biophys Acta (1973) 3.75
Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta (1975) 2.62
In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res (1980) 2.40
Local anesthetics affect transmembrane cytoskeletal control of mobility and distribution of cell surface receptors. Proc Natl Acad Sci U S A (1975) 2.26
Studies on membrane fusion. III. The role of calcium-induced phase changes. Biochim Biophys Acta (1977) 2.15
Effects of local anesthetics on membrane properties. I. Changes in the fluidity of phospholipid bilayers. Biochim Biophys Acta (1975) 1.89
Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci U S A (1981) 1.87
Growth factor production by human colon carcinoma cell lines. Cancer Res (1989) 1.82
Mechanisms of virus-induced cell fusion. Int Rev Cytol (1972) 1.79
Membrane fusion and molecular segregation in phospholipid vesicles. Biochim Biophys Acta (1974) 1.73
Lipid vesicles as carriers for introducing biologically active materials into cells. Methods Cell Biol (1976) 1.70
Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U S A (1980) 1.65
Fusion of mammalian cells by unilamellar lipid vesicles: inflluence of lipid surface charge, fluidity and cholesterol. Biochim Biophys Acta (1973) 1.63
The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother (1997) 1.62
Studies on membrane fusion. II. Induction of fusion in pure phospholipid membranes by calcium ions and other divalent metals. Biochim Biophys Acta (1976) 1.51
The cancer cell: dynamic aspects and modifications in cell-surface organization (first of two parts). N Engl J Med (1976) 1.51
Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. Proc Natl Acad Sci U S A (1976) 1.48
Effects of local anesthetics on membrane properties. II. Enhancement of the susceptibility of mammalian cells to agglutination by plant lectins. Biochim Biophys Acta (1975) 1.46
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis (1988) 1.43
Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res (1982) 1.40
Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells. Proc Natl Acad Sci U S A (1985) 1.38
Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature (1974) 1.33
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res (1982) 1.32
Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc Natl Acad Sci U S A (1982) 1.31
Herpesvirus hominis infection of the female genital tract. Obstet Gynecol (1972) 1.31
Virus-induced polykaryocytosis and the mechanism of cell fusion. Adv Virus Res (1970) 1.28
Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J Immunol (1984) 1.25
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res (1980) 1.23
Membrane fusion reaction: a theory. J Theor Biol (1971) 1.17
Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res (1998) 1.15
Effects of local anesthetics on cell morphology and membrane-associated cytoskeletal organization in BALB/3T3 cells. J Cell Biol (1976) 1.15
Induction of 32- and 34-kDa stress proteins by sodium arsenite, heavy metals, and thiol-reactive agents. J Biol Chem (1986) 1.14
The study of cellular "microexudates" by ellipsometry and their relationship to the cell coat. Exp Cell Res (1973) 1.12
Tissue dissociation with proteolytic enzymes. Adsorption and activity of enzymes at the cell surface. Exp Cell Res (1971) 1.11
Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res (1981) 1.11
A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope. AIDS Res Hum Retroviruses (1993) 1.10
Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res (1979) 1.09
Cellular uptake of cyclic AMP captured within phospholipid vesicles and effect on cell-growth behaviour. Biochim Biophys Acta (1974) 1.08
Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc Natl Acad Sci U S A (1993) 1.07
Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases. Cancer Res (1982) 1.06
Rational or rationed medicine? The promise of genetics for improved clinical practice. BMJ (2000) 1.06
Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines. J Immunol (1980) 1.05
Increased mobility and redistribution of concanavalin A receptors on cells infected with Newcastle disease virus. Nature (1974) 1.05
Studies on membrane fusion. I. Interactions of pure phospholipid membranes and the effect of myristic acid, lysolecithin, proteins and dimethylsulfoxide. Biochim Biophys Acta (1976) 1.05
Tumor implantation and invasion at metastatic sites. Int Rev Exp Pathol (1983) 1.04
Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. J Immunol (1986) 1.04
Enucleation of mammalian cells by cytochalasin B. I. Characterization of anucleate cells. Exp Cell Res (1972) 1.03
Experimental systems for analysis of the malignant phenotype. Cancer Metastasis Rev (1982) 1.02
Cells transformed by temperature-sensitive mutants of avian sarcoma virus cause tumors in vivo at permissive and nonpermissive temperatures. Cell (1979) 1.02
Improved flow cytometric analysis of leukocyte subsets: simultaneous identification of five cell subsets using two-color immunofluorescence. Proc Natl Acad Sci U S A (1986) 1.01
Inhibition of cell fusion by local anaesthetics and tranquillizers. Exp Cell Res (1972) 1.00
Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. Cancer Res (1979) 1.00
Tumor heterogeneity and progression: conceptual foundations for modeling. Invasion Metastasis (1996) 1.00
SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. Biochem Pharmacol (1987) 0.99
The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells. Am J Pathol (1979) 0.99
Studies on the cytopathogenicity of Newcastle disease virus: relation between virulence, polykaryocytosis and plaque size. J Gen Virol (1971) 0.99
Inhibition of macrophage activation by calcium channel blockers and calmodulin antagonists. Cell Immunol (1985) 0.98
Identification and characterization of a monoclonal antibody to an antigen expressed on activated macrophages. Proc Natl Acad Sci U S A (1984) 0.98
Inhibition of phytohaemagglutinin-induced proliferation of human peripheral blood lymphocytes by histamine and histamine H1 and H2 agonists. Clin Exp Immunol (1983) 0.98
Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Cancer Treat Rep (1986) 0.96
Cellular binding of 3H-cytochalasin B. J Cell Physiol (1974) 0.96
Studies on the cytopathic effects of Newcastle disease virus: metabolic requirements. J Gen Virol (1971) 0.96
The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin Oncol (1985) 0.95
New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. JAMA (1996) 0.95
The impact of health checks for people with intellectual disabilities: a systematic review of evidence. J Intellect Disabil Res (2011) 0.94
Modification of Newcastle disease virus release and cytopathogenicity in cells treated with plant lectins. J Gen Virol (1974) 0.94
Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines. Int J Cancer (1989) 0.94
Tumor cell diversity and host responses in cancer metastasis--part I--properties of metastatic cells. Curr Probl Cancer (1982) 0.94
Sub-lethal autolysis. Modification of cell periphery by lysosomal enzymes. Exp Cell Res (1971) 0.93
The influence of vesicle membrane properties on the interaction of lipid vesicles with cultured cells. Ann N Y Acad Sci (1978) 0.92
The cancer cell: dynamic aspects and modification in cell-surface organization (second of two parts). N Engl J Med (1976) 0.92
Agglutination of normal cells by plant lectins following infection with nononcogenic viruses. Nat New Biol (1972) 0.90
Virus-induced cell fusion enhanced by phytohaemagglutinin. Nature (1974) 0.89
Calcium ionophores A23187 and X537A affect cell agglutination by lectins and capping of lymphocyte surface immunoglobulins. Biochim Biophys Acta (1976) 0.88
Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease. Springer Semin Immunopathol (1982) 0.88
Local anaesthetics increase susceptibility of untransformed cells to agglutination by concanavalin A. Nature (1975) 0.88
Interaction of Sendai virus with human erythrocytes: a system for the study of membrane fusion. Microbios (1972) 0.88
Characterization of an animal model of metastatic colon carcinoma. Int J Cancer (1987) 0.88
The growth and cytopathogenicity of virulent and attenuated strains of canine distemper virus in dog and ferret macrophages. J Comp Pathol (1971) 0.87
Studies on the cytopathic effects of Newcastle disease virus: cell surface changes. J Gen Virol (1972) 0.86
Cell surface receptors for lymphokines. I. The possible role of glycolipids as receptors for macrophage migration inhibitory factor (MIF) and macrophage activation factor (MAF). Cell Immunol (1979) 0.86
Coupling of TGF-beta-induced mitogenesis to G-protein activation in AKR-2B cells. Biochem Biophys Res Commun (1988) 0.86
Macrophage content of spontaneous metastases at different stages of growth. Cancer Res (1987) 0.86
Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. J Bone Miner Res (1993) 0.86
Changes in susceptibility of normal cells to agglutination by plant lectins following modification of cell coat material. Exp Cell Res (1972) 0.86
Inhibition of virus-induced cell fusion by local anaesthetics and phenothiazine tranquilizers. J Gen Virol (1972) 0.85
Fusion of mammalian cells by lipid vesicles. Methods Cell Biol (1976) 0.85
Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines. Cancer Res (1975) 0.85
Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells. Cancer Res (1985) 0.85
Cell surface receptors for lymphokines. II. Studies on the carbohydrate composition of the MIF receptor on macrophages using synthetic saccharides and plant lectins. Cell Immunol (1979) 0.85
Streptomyces: a host for heterologous gene expression. Curr Opin Biotechnol (1991) 0.84
The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes. Cancer Res (1981) 0.84
Tumor cell diversity and host responses in cancer metastasis--part II--host immune responses and therapy of metastases. Curr Probl Cancer (1983) 0.84